Stem Cell Research for Future Therapies and In Vitro Disease Modelling

Dear Colleagues,

In recent years, stem cell therapy has emerged as a very promising and advanced scientific research topic that is currently undergoing its first clinical trials. This growing interest coincides with industrial partners aims to scale up technology and capacity and provide cell replacement therapies to patients suffering from chronic disorders.

This Special Issue focuses on recent discoveries that may contribute to the areas of basic and molecular stem cell research, in vitro disease modelling, molecular stem cell biology, exosomes, translational stem cell research, and stem cell therapies. Recent advances in cell reprogramming and genome editing technologies have created new possibilities for the development of novel in vitro models to study human diseases. More recently, organoids have emerged as a powerful tool to better study early developmental biology and as a potential source for future cell therapies.

Cell-replacement therapies are entering a new phase of growth, and novel discoveries for molecular characterization, cell differentiation, expansion, purification, raw materials, and delivery under GMP conditions are critical for moving stem cell products from bench to bedside.

We invite you to contribute to this Special Issue and communicate original articles and reviews on new advances in stem cell research for future therapies and in vitro disease modelling.

Dr. J. Carlos Villaescusa
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.